EUVIMEDEUVIMED entdecken
Crossref

The Tumor-Suppressive Role of miR-204-5p Through Targeting Ezrin in Breast Cancer: Experimental Evidence From Cell Lines and Clinical Samples

Tianfu Dong, Honglei Zhou, Jinhai Tang

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2025.02.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Tianfu Dong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Lianyungang Clinical College of Nanjing Medical University, The First People Hospital of Lianyungang City, Lianyungang, China; Department of General …. Hauptthemen laut MEDLINE: MicroRNAs, Breast Neoplasms, Cytoskeletal Proteins. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsBreast NeoplasmsCytoskeletal ProteinsHumansFemaleCell ProliferationGene Expression Regulation, NeoplasticPrognosisCell MovementDown-RegulationCell Line, TumorMiddle AgedBiomarkers, TumorSignal TransductionGenes, Tumor SuppressorEzrin

Stichwörter der Autor:innen

AKT pathwayEMTcell proliferationmicroRNA

Substanzen

MicroRNAsCytoskeletal ProteinsBiomarkers, TumorEzrinMIRN204 microRNA, human

Autor:innen und Institutionen

  • Lianyungang Clinical College of Nanjing Medical University, The First People Hospital of Lianyungang City, Lianyungang, China; Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University,…
  • Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Electronic address: jhtang@njmu.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Dong, T., Zhou, H., & Tang, J. (2025). The Tumor-Suppressive Role of miR-204-5p Through Targeting Ezrin in Breast Cancer: Experimental Evidence From Cell Lines and Clinical Samples. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2025.02.013

Vancouver

Dong T, Zhou H, Tang J. The Tumor-Suppressive Role of miR-204-5p Through Targeting Ezrin in Breast Cancer: Experimental Evidence From Cell Lines and Clinical Samples. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2025.02.013

BibTeX
@article{Dong2025,
  author = {Dong, Tianfu and Zhou, Honglei and Tang, Jinhai},
  title = {The Tumor-Suppressive Role of miR-204-5p Through Targeting Ezrin in Breast Cancer: Experimental Evidence From Cell Lines and Clinical Samples},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2025.02.013}
}
Kostenlos starten →